Publications found:
55,654
Sort by:
Achondroplasia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ACHONDROPLASIA PIPELINE REPORT INCLUDES Panorama of Achondroplasia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Acid Sphingomyelinase Deficiency (NPD C) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF ACID SPHINGOMYELINASE DEFICIENCY (NPD C) PIPELINE REPORT INCLUDES Panorama of Acid Sphingomyelinase Deficiency (NPD C) pipeline markets including statistics on therapeutic drugs and companies involved Acid Sphingomyelinase Deficiency (NPD C) Pipeline candidates across ...
August 2018
60 pages
Acinetobacter Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ACINETOBACTER INFECTIONS PIPELINE REPORT INCLUDES Panorama of Acinetobacter Infections pipeline markets including statistics on therapeutic drugs and companies involved Acinetobacter Infections Pipeline candidates across various development ...
August 2018
120 pages
Acne Vulgaris R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ACNE VULGARIS PIPELINE REPORT INCLUDES Panorama of Acne Vulgaris pipeline markets including statistics on therapeutic drugs and companies involved Acne Vulgaris Pipeline candidates across various development ...
August 2018
150 pages
Acromegaly R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ACROMEGALY PIPELINE REPORT INCLUDES Panorama of Acromegaly pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Actinic (Solar) Keratosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ACTINIC (SOLAR) KERATOSIS PIPELINE REPORT INCLUDES Panorama of Actinic (Solar) Keratosis pipeline markets including statistics on therapeutic drugs and companies involved Actinic (Solar) Keratosis Pipeline candidates across various development ...
August 2018
50 pages
Acute Coronary Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ACUTE CORONARY SYNDROME PIPELINE REPORT INCLUDES Panorama of Acute Coronary Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Acute Coronary Syndrome Pipeline candidates across various development ...
August 2018
90 pages
Acute Heart Failure R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ACUTE HEART FAILURE PIPELINE REPORT INCLUDES Panorama of Acute Heart Failure pipeline markets including statistics on therapeutic drugs and companies involved Acute Heart Failure Pipeline candidates across various development ...
August 2018
60 pages
Acute Ischemic Stroke R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ACUTE ISCHEMIC STROKE PIPELINE REPORT INCLUDES Panorama of Acute Ischemic Stroke pipeline markets including statistics on therapeutic drugs and companies involved Acute Ischemic Stroke Pipeline candidates across various development ...
August 2018
100 pages
Acute Lung Injury R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ACUTE LUNG INJURY PIPELINE REPORT INCLUDES Panorama of Acute Lung Injury pipeline markets including statistics on therapeutic drugs and companies involved Acute Lung Injury Pipeline candidates across various development ...
August 2018
80 pages
Acute Pain R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ACUTE PAIN PIPELINE REPORT INCLUDES Panorama of Acute Pain pipeline markets including statistics on therapeutic drugs and companies involved Acute Pain Pipeline candidates across various development ...
August 2018
160 pages
Acute Renal Failure (ARF) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF ACUTE RENAL FAILURE (ARF) PIPELINE REPORT INCLUDES Panorama of Acute Renal Failure (ARF) pipeline markets including statistics on therapeutic drugs and companies involved Acute Renal Failure (ARF) Pipeline candidates across ...
August 2018
100 pages
Acute Respiratory Distress Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF ACUTE RESPIRATORY DISTRESS SYNDROME PIPELINE REPORT INCLUDES Panorama of Acute Respiratory Distress Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Acute Respiratory Distress Syndrome Pipeline candidates across ...
August 2018
80 pages
Acute Sensorineural Hearing Loss R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF ACUTE SENSORINEURAL HEARING LOSS PIPELINE REPORT INCLUDES Panorama of Acute Sensorineural Hearing Loss pipeline markets including statistics on therapeutic drugs and companies involved Acute Sensorineural Hearing Loss Pipeline candidates across ...
August 2018
40 pages
Adrenocortical Carcinoma (Adrenal Cortex Cancer) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF ADRENOCORTICAL CARCINOMA (ADRENAL CORTEX CANCER) PIPELINE REPORT INCLUDES Panorama of Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline markets including statistics on therapeutic drugs and companies involved Adrenocortical Carcinoma (Adrenal Cortex Cancer) Pipeline candidates across ...
August 2018
90 pages
Adrenoleukodystrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ADRENOLEUKODYSTROPHY PIPELINE REPORT INCLUDES Panorama of Adrenoleukodystrophy pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
African Trypanosomiasis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF AFRICAN TRYPANOSOMIASIS PIPELINE REPORT INCLUDES Panorama of African Trypanosomiasis pipeline markets including statistics on therapeutic drugs and companies involved African Trypanosomiasis Pipeline candidates across various development ...
August 2018
40 pages
Alcohol Addiction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ALCOHOL ADDICTION PIPELINE REPORT INCLUDES Panorama of Alcohol Addiction pipeline markets including statistics on therapeutic drugs and companies involved Alcohol Addiction Pipeline candidates across various development ...
August 2018
110 pages
Alcoholic Hepatitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ALCOHOLIC HEPATITIS PIPELINE REPORT INCLUDES Panorama of Alcoholic Hepatitis pipeline markets including statistics on therapeutic drugs and companies involved Alcoholic Hepatitis Pipeline candidates across various development ...
August 2018
60 pages
Allergic Conjunctivitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ALLERGIC CONJUNCTIVITIS PIPELINE REPORT INCLUDES Panorama of Allergic Conjunctivitis pipeline markets including statistics on therapeutic drugs and companies involved Allergic Conjunctivitis Pipeline candidates across various development ...
August 2018
60 pages
Allergic Rhinitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ALLERGIC RHINITIS PIPELINE REPORT INCLUDES Panorama of Allergic Rhinitis pipeline markets including statistics on therapeutic drugs and companies involved Allergic Rhinitis Pipeline candidates across various development ...
August 2018
100 pages
Alopecia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ALOPECIA PIPELINE REPORT INCLUDES Panorama of Alopecia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Alpha Antitrypsin Deficiency R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... comprehensive information of AlphaAntitrypsin Deficiency pipeline products. The AlphaAntitrypsin Deficiency pipeline guide presents complete ... use format. SCOPE OF ALPHA%LI%ANTITRYPSIN DEFICIENCY PIPELINE REPORT INCLUDES Panorama of AlphaAntitrypsin Deficiency pipeline markets including statistics on ...
August 2018
70 pages
Amyloidosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF AMYLOIDOSIS PIPELINE REPORT INCLUDES Panorama of Amyloidosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
150 pages
Anal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ANAL CANCER PIPELINE REPORT INCLUDES Panorama of Anal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Anal Cancer Pipeline candidates across various development ...
August 2018
190 pages
Anaphylaxis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ANAPHYLAXIS PIPELINE REPORT INCLUDES Panorama of Anaphylaxis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Anaplastic Astrocytoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ANAPLASTIC ASTROCYTOMA PIPELINE REPORT INCLUDES Panorama of Anaplastic Astrocytoma pipeline markets including statistics on therapeutic drugs and companies involved Anaplastic Astrocytoma Pipeline candidates across various development ...
August 2018
130 pages
Anaplastic Large Cell Lymphoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF ANAPLASTIC LARGE CELL LYMPHOMA PIPELINE REPORT INCLUDES Panorama of Anaplastic Large Cell Lymphoma pipeline markets including statistics on therapeutic drugs and companies involved Anaplastic Large Cell Lymphoma Pipeline candidates across ...
August 2018
80 pages
Anaplastic Oligoastrocytoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ANAPLASTIC OLIGOASTROCYTOMA PIPELINE REPORT INCLUDES Panorama of Anaplastic Oligoastrocytoma pipeline markets including statistics on therapeutic drugs and companies involved Anaplastic Oligoastrocytoma Pipeline candidates across various development ...
August 2018
60 pages
Anaplastic Thyroid Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ANAPLASTIC THYROID CANCER PIPELINE REPORT INCLUDES Panorama of Anaplastic Thyroid Cancer pipeline markets including statistics on therapeutic drugs and companies involved Anaplastic Thyroid Cancer Pipeline candidates across various development ...
August 2018
60 pages
Androgenic Alopecia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ANDROGENIC ALOPECIA PIPELINE REPORT INCLUDES Panorama of Androgenic Alopecia pipeline markets including statistics on therapeutic drugs and companies involved Androgenic Alopecia Pipeline candidates across various development ...
August 2018
60 pages
Anesthetic Effect R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ANESTHETIC EFFECT PIPELINE REPORT INCLUDES Panorama of Anesthetic Effect pipeline markets including statistics on therapeutic drugs and companies involved Anesthetic Effect Pipeline candidates across various development ...
August 2018
70 pages
Angina (Angina Pectoris) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ANGINA (ANGINA PECTORIS) PIPELINE REPORT INCLUDES Panorama of Angina (Angina Pectoris) pipeline markets including statistics on therapeutic drugs and companies involved Angina (Angina Pectoris) Pipeline candidates across various development ...
August 2018
60 pages
Ankylosing Spondylitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ANKYLOSING SPONDYLITIS PIPELINE REPORT INCLUDES Panorama of Ankylosing Spondylitis pipeline markets including statistics on therapeutic drugs and companies involved Ankylosing Spondylitis Pipeline candidates across various development ...
August 2018
160 pages
Anthrax R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ANTHRAX PIPELINE REPORT INCLUDES Panorama of Anthrax pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
90 pages
Aplastic Anemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF APLASTIC ANEMIA PIPELINE REPORT INCLUDES Panorama of Aplastic Anemia pipeline markets including statistics on therapeutic drugs and companies involved Aplastic Anemia Pipeline candidates across various development ...
August 2018
60 pages
Arrhythmias R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ARRHYTHMIAS PIPELINE REPORT INCLUDES Panorama of Arrhythmias pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Arterial Thrombosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ARTERIAL THROMBOSIS PIPELINE REPORT INCLUDES Panorama of Arterial Thrombosis pipeline markets including statistics on therapeutic drugs and companies involved Arterial Thrombosis Pipeline candidates across various development ...
August 2018
30 pages
Aspergillosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ASPERGILLOSIS PIPELINE REPORT INCLUDES Panorama of Aspergillosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
100 pages
Atherosclerosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ATHEROSCLEROSIS PIPELINE REPORT INCLUDES Panorama of Atherosclerosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
190 pages
Atrial Fibrillation R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ATRIAL FIBRILLATION PIPELINE REPORT INCLUDES Panorama of Atrial Fibrillation pipeline markets including statistics on therapeutic drugs and companies involved Atrial Fibrillation Pipeline candidates across various development ...
August 2018
80 pages
Atrophic Macular Degeneration R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ATROPHIC MACULAR DEGENERATION PIPELINE REPORT INCLUDES Panorama of Atrophic Macular Degeneration pipeline markets including statistics on therapeutic drugs and companies involved Atrophic Macular Degeneration Pipeline candidates across various development ...
August 2018
110 pages
Atrophic Vaginitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ATROPHIC VAGINITIS PIPELINE REPORT INCLUDES Panorama of Atrophic Vaginitis pipeline markets including statistics on therapeutic drugs and companies involved Atrophic Vaginitis Pipeline candidates across various development ...
August 2018
30 pages
Attention Deficit Hyperactivity Disorder (ADHD) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) PIPELINE REPORT INCLUDES Panorama of Attention Deficit Hyperactivity Disorder (ADHD) pipeline markets including statistics on therapeutic drugs and companies involved Attention Deficit Hyperactivity Disorder (ADHD) Pipeline candidates across ...
August 2018
130 pages
Atypical Hemolytic Uremic Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... comprehensive information of Atypical Hemolytic Uremic Syndrome pipeline products. The Atypical Hemolytic Uremic Syndrome pipeline guide presents complete overview of drugs currently being developed for Atypical Hemolytic Uremic Syndrome (NondiarrheaAssociated Hemolytic Uremic Syndrome) . The pipeline ...
August 2018
70 pages
Autism R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF AUTISM PIPELINE REPORT INCLUDES Panorama of Autism pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
140 pages
Axial Spondyloarthritis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF AXIAL SPONDYLOARTHRITIS PIPELINE REPORT INCLUDES Panorama of Axial Spondyloarthritis pipeline markets including statistics on therapeutic drugs and companies involved Axial Spondyloarthritis Pipeline candidates across various development ...
August 2018
90 pages
